Dabos KJ. New markers of fibrosis in hepatitis C: A step towards the Holy Grail? World J Hepatol 2024; 16(2): 112-114 [PMID: 38495275 DOI: 10.4254/wjh.v16.i2.112]
Corresponding Author of This Article
Konstantinos John Dabos, MD, PhD, Doctor, Department of Hepatology, St Hohn's Hospital, Howden Road West, Livingston EH54 6PP, West lothian, United Kingdom. konstantinos.dabos@nhslothian.scot.nhs.uk
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/